Latest Licensing News

ikeGPS delivered a robust 4Q FY25 with a 48% jump in annual subscription revenue and closed NZ$12 million in contracts, while receiving a non-binding acquisition approach valuing the company at around NZ$165-170 million.

ikeGPS Group Limited reported a robust 48% increase in annual subscription revenue exit run rate for FY25, driven by major U.S. utility contracts, while declining a non-binding $170 million acquisition offer due to shareholder resistance.

Minerals 260 Limited has launched a $200-$220 million public offer to fund the acquisition of the Bullabulling Gold Project in Western Australia, featuring a 2.3 million ounce JORC-compliant resource. The company seeks ASX re-admission following a significant change in scale of activities.

Mt Malcolm Mines NL has reached a significant production milestone within 3.5 years of its ASX listing, generating initial revenue from gold sales while expanding its exploration footprint across multiple prospects in Western Australia's Leonora region.

Provaris Energy has launched a capital-lite revenue model designed to generate early cash flow with minimal capital expenditure, alongside securing a major hydrogen supply agreement with Uniper Global Commodities. The company targets first hydrogen deliveries by early 2029, advancing its position in Europe's hydrogen supply chain.

Adriatic Metals has announced a A$80 million equity raising aimed at fast-tracking the expansion of its Vares Silver Operation in Bosnia and Herzegovina, supporting increased production capacity and strengthening its balance sheet.

AUCyber Limited reported a substantial $19.5 million net loss for the half-year ended December 2024, driven by a $14.7 million impairment following underperformance post-merger. The company has since received and recommended a takeover bid from 5G Networks Limited.

Li-S Energy reports a $2.67 million net loss for H1 FY25 but marks significant milestones in lithium sulfur battery production and strategic partnerships.

Judo Capital Holdings Limited reported a robust 54% increase in statutory profit before tax for the half year ended December 2024, driven by strong SME loan growth and prudent cost management, despite a slight dip in net interest margin and statutory profit after tax.

PYC Therapeutics has launched a A$145.8 million pro-rata accelerated non-renounceable entitlement offer to fund late-stage clinical trials across its pipeline targeting rare diseases with high unmet needs. The capital raise aims to extend the company’s cash runway beyond FY27, supporting four drug candidates through critical human safety and efficacy milestones.

Memphasys has initiated clinical utility testing of its Felix™ System in Brazil through a partnership with Laboratorio Androscience, aiming to establish a foothold in the rapidly growing Latin American IVF sector.

Thor Energy has completed its acquisition of an 80.2% interest in Go Exploration, gaining access to prime hydrogen and helium exploration licenses in South Australia and significantly expanding its clean energy portfolio.